Clinics in Laboratory Medicine

Papers
(The median citation count of Clinics in Laboratory Medicine is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Strategic Leadership in Laboratory Medicine: Navigating Belonging, Resilience, and Organizational Culture21
Forthcoming Issues18
Digital Imaging and AI Pre-classification in Hematology15
Promoting Health Equity Through Effective Laboratory Stewardship Strategies15
Current Topics in Molecular Diagnostics and Precision Medicine14
Molecular Detection of Oncogenic Gene Rearrangements13
Molecular Pathology of Ovarian Epithelial Neoplasms11
Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists11
Point-of-Care Drug Testing11
Contributors11
Automated Quality Assurance Rules for Liquid Chromatography–Mass Spectrometry Testing in a Clinical Laboratory10
Molecular Oncology Diagnostics10
Copy Number Analysis in Cancer Diagnostic Testing10
Is It Possible to Test for Viral Infectiousness?10
Leadership's Role in Paving the Path to Diversity, Equity, and Inclusion in Laboratory Medicine10
Inclusive Laboratory Reference Intervals and Clinical Studies to Reduce Health Disparities9
Flow Cytometry-based Immune Phenotyping of T and B Lymphocytes in the Evaluation of Immunodeficiency and Immune Dysregulation9
Perspectives on Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 and Its Implications for Diagnostics, Biology, and Clinical Management8
Flow Cytometry in Diagnosis, Prognostication, and Monitoring of Multiple Myeloma and Related Disorders8
Contributors8
Cell-free Nucleic Acids in Cancer8
Opportunities and Challenges with Artificial Intelligence in Genomics8
Nothing Basic About It: Guiding the Judicious Use of Diagnostic Tests8
Flow Cytometry and Platelets8
Contributors8
Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing7
Contextualizing Race and Ethnicity in the Practice of Laboratory Medicine7
Leadership Approaches for Work-Life Balance, Well-Being, and Diversity, Equity, and Inclusion Support in the Laboratory7
Contents7
Diagnostic Stewardship for Next-Generation Sequencing Assays in Clinical Microbiology7
Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP537
Artificial Intelligence for Clinical Flow Cytometry7
Contents6
Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-195
Morphologic Characteristics of Myelodysplastic Syndromes5
Steps Forward to a Fair and Inclusive Blood Supply5
Implementation of Viscoelastic Testing at the Point of Care5
Expanding the Blood Donor Pool5
The Evolving Role of Molecular Diagnostics in Pathology5
Copyright5
Molecular Alterations in Pediatric Solid Tumors5
Copyright5
An Overview of SARS-CoV-2 Molecular Diagnostics in Europe5
The Impact of Inclusive Excellence Initiatives on Laboratory Wellness5
Electronic Health Record Optimization for Artificial Intelligence5
Transfusion Medicine: Renovation, Innovation, and Evolution4
Molecular Biomarkers of Response to Cancer Immunotherapy4
Taking Center Stage4
Rapid Antigen Assays for SARS-CoV-24
Copyright4
Molecular Diagnostics for Invasive Molds: From Lab to Bedside4
The Mass Spectrometry Revolution in Clinical Microbiology Part 24
Point of Care Molecular Testing4
Hemostatic Disorders Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection, COVID-19 Vaccination, and Long-COVID Syndrome4
Artificial Intelligence in the Clinical Laboratory4
Review of Established and Emerging Infectious Diseases in Transfusion Medicine4
The Role of Artificial Intelligence in Transfusion Medicine4
Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance)4
Utility of Single-Gene Testing in Cancer Specimens4
von Willebrand Disease and von Willebrand Factor4
Bacterial Risk Mitigation Strategies for Platelets3
Value of Improving Result Interpretation in Direct-to-Definitive Urine Drug Panels3
A Meta-analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Anti-spike Immunoglobulin G Antibody Durability up to 9 Months After Full Vaccination in Adults3
Performance of Non-nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-23
Contents3
Molecular Methods3
Copyright3
Influence of Race Modifiers in Estimated Glomerular Filtration Rate Calculations on Medication Dosing, Access, and Transplant Eligibility3
Contents3
Suboptimal Humoral Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Viral Variant Generation3
Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology3
Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms3
An Overview of Common Donor and Therapeutic Apheresis Procedures3
Contributors3
Diagnostic Stewardship for Multiplex Respiratory Testing3
Copyright3
Update on Ovarian Sex Cord–Stromal Tumors3
Specimen Validity Testing in the Toxicology Laboratory2
Clinical Cytometry for Platelets and Platelet Disorders2
Contributors2
Molecular Pathology of Prostate Cancer2
Copyright2
Childhood Myelodysplastic Syndrome2
History, Advances, and Challenges of Sickle Cell Disease Treatment2
Contents2
Racism in Drug Testing2
Implementation of the Individual Risk Assessment and Changes to Deferral Periods Since 20202
System-Wide Leadership2
Pathology Clinics Can Address Pathology Burnout2
Analytical Principles of Cancer Next Generation Sequencing2
Promoting Gender Equality in Pathology and Laboratory Medicine Leadership2
Flow Cytometric Assessment of Malignant Hematologic Disorders2
Artificial Intelligence in the Genetic Diagnosis of Rare Disease2
Current Topics in Molecular Diagnostics and Precision Medicine2
A Winding Road to Health Care Equity in Sickle Cell Disease2
Molecular Pathology of Breast Tumors2
SARS-CoV-2 Molecular Diagnostics in China1
Best Practice for Clinical Somatic Variant Interpretation and Reporting1
Leadership Development for Pathology and Laboratory Medicine Residents and Fellows1
Antibody Dynamics and Durability in Coronavirus Disease-191
Molecular Approach to Colorectal Carcinoma1
Transfusion Support of Patients with Myelodysplastic Syndromes1
Reflexive Drug Testing Strategies for Efficient Utilization of Resources and Better Interpretation1
Forthcoming Issues1
Approaches to Deployment of Molecular Testing for SARS-CoV-2 in Resource-Limited Settings1
Epidemiology and Diagnosis of Lyme Disease in the United States1
Will Antigen Testing Remain Relevant in the Point-of-Care Testing Environment?1
Reshaping Organizational Culture in Pathology1
Patient Blood Management and Blood Product Alternatives1
The Advancement of Infectious Diseases Diagnostics1
Copyright1
The Role of the Human Gutome on Chronic Disease1
Contents1
Specimen Considerations in Molecular Oncology Testing1
Advances in Clinical Mass Cytometry1
Contents1
Advances and Progress in Automated Urine Analyzers1
Detection of Fentanyl and Fentanyl Analogs1
Addressing Health Disparities in Clinical Pathology and Laboratory Medicine1
Optimizing Therapeutic Drug Monitoring of Anti-infectives1
Contributors1
Cycle Threshold Values from Severe Acute Respiratory Syndrome Coronavirus-2 Reverse Transcription-Polymerase Chain Reaction Assays1
Utility of Flow Cytometry Analysis in the Detection of Nonhematologic Neoplasms1
Diagnosing Chagas in Pregnancy and Childhood1
Affirmative Healthcare for Transgender and Gender Nonconforming Patients1
The Immunophenotypic Profile of Healthy Human Bone Marrow1
Covid-19 Molecular Testing and Clinical Correlates1
Forthcoming Issues1
Molecular Pathology of Myeloid Neoplasms1
Kidney Tumors1
Molecular Testing Expansion and Utilization in Transfusion Medicine1
Utility of Fluorescence In Situ Hybridization in Clinical and Research Applications1
Diagnostics Stewardship in Molecular Microbiology: From at-home Testing to Next-Generation Sequencing1
Contributors1
Interpreting Toxicology Results in Perinatal and Newborn Specimens1
Hematology Laboratory in the Digital and Automation Age1
Point-of-Care Testing for the Diagnosis of Fungal Infections1
Pathogen-Reduce Cryoprecipitate1
Copyright1
Contributors1
Using Artificial Intelligence to Better Predict and Develop Biomarkers0
Replacement of Culture with Molecular Testing for Diagnosis Infectious Diseases0
Contents0
Forthcoming Issues0
Literacy and Language Barriers to Overcome in Laboratory Medicine0
Interpretation of Bacterial Smears and Cultures Using Artificial Intelligence0
High-throughput Sequencing in the Diagnosis of Inherited Bleeding and Clotting Disorders0
Disseminated Intravascular Coagulation and Advances in D-Dimer Testing0
Forthcoming Issues0
Opportunities and Drawbacks of Digitalized Morphologic Analysis of Body Fluids0
Special Hematology Laboratory Testing: Emerging Concepts and Novel Approaches0
Practical Considerations for Implementing Targeted Mass Spectrometry for Urine Drug Testing in Clinical Laboratories0
Evolving Approach to Clinical Cytometry for Immunodeficiencies and Other Immune Disorders0
Molecular Pathology of Thyroid Tumors0
Germline Testing for the Evaluation of Hereditary Cancer Predisposition0
Forthcoming Issues0
Copyright0
Forthcoming Issues0
Advances in Bone Marrow Evaluation0
Contents0
Contents0
Regulatory Approach to Point-of-Care/At-Home Testing in the United States0
Next-Generation Sequencing Approaches to Predicting Antimicrobial Susceptibility Testing Results0
Advances in Clinical Toxicology Testing0
The Medical Practice of Molecular Oncology Diagnostics0
A Tale of Trial and Triumph: Molecular Diagnostics for Severe Acute Respiratory Coronavirus 2 Over the First Two Years of the Coronavirus Disease 2019 Pandemic0
Disaster Preparedness0
Alternative Methods to Detect Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies0
Strategies for Scaling up SARS-CoV-2 Molecular Testing Capacity0
Recent Advances in Therapeutic Drug Monitoring of Antineoplastic and Antimicrobial Agents in Children0
Candida auris Diagnostics0
Molecular Pathology of Gliomas0
Testing Strategies and the Emergence of Designer Benzodiazepines0
Infectious Diseases Diagnostics: From Current Strategies to Future Technologies0
Advances in Acute Myeloid Leukemia Classification, Prognostication and Monitoring by Flow Cytometry0
The Role of Point-of-Care Testing in Specific Populations0
Clinical Artificial Intelligence0
Advances in Hematology Analyzers Technology0
Herpes B Virus0
HLA Typing by Next-Generation Sequencing0
Access Barriers in Testing for Sexually Transmitted Infections across Gender and Sexual Identities0
Advances in Chromatography-Free and Ambient Ionization Mass Spectrometry Techniques Toward Clinical Toxicology Testing0
Contributors0
Contents0
Advances in Myelodysplastic Syndromes0
Practical Considerations for Implementing Immunoassays for Urine Drug Testing in Clinical Laboratories0
Copyright0
Contents0
Diagnosis of Tick-Borne Diseases in New England0
Molecular Techniques and Gene Mutations in Myelodysplastic Syndromes0
Molecular Pathology of Lung Cancer0
Home and Clinical Laboratory Improvement Amendments–Waived Testing for Infectious Diseases—How Do These Fit in the Testing Landscape?0
Laboratory Aspects of Minimal / Measurable Residual Disease Testing in B-Lymphoblastic Leukemia0
Pediatric Toxicology0
Forthcoming Issues0
Machine Learning and Artificial Intelligence-Based Clinical Decision Support for Modern Hematology0
Copyright0
Women’s and Transgender Issues in Thrombosis and Hemostasis0
Automation in Flow Cytometry0
When Tissue Is the Issue0
The Enduring and Expanding Importance of Clinical Cytometry0
Contributors0
Laboratory Informatics Approaches to Improving Care for Gender- Diverse Patients0
Practical Challenges of Point-of-Care Testing0
Special Considerations in the Molecular Diagnostics of Pediatric Neoplasms0
Alcohol and Drug Testing in Motor Vehicle Crashes0
Contributors0
Untargeted Mass Spectrometry Applications for Clinical Toxicology0
Detecting Xylazine0
Advances in Monitoring and Prognostication for Lymphoma by Flow Cytometry0
Artificial Intelligence in the Clinical Laboratory0
A New Landscape of Testing and Therapeutics in Metastatic Breast Cancer0
Preface0
Current Trends in Identification and Susceptibility Testing of Mycobacteria0
Precision Medicine Using Pharmacogenomic Panel-Testing0
Forthcoming Issues0
Advances in Clinical Toxicology Testing0
The Successes and Challenges of SARS-CoV-2 Molecular Testing in the United States0
How to Design and Validate a Clinical Flow Cytometry Assay0
The Report Says What?0
Recent Advances in Extended Half-Life Products, Nonfactor Replacement Therapies, and Gene Therpy for the Treatment of Hemophilia0
Artificial Intelligence Applications in Clinical Chemistry0
The Essential Role of Leadership in Laboratory Medicine0
Myelodysplastic Syndromes0
Contents0
Advances in Flow Cytometry for Mixed Phenotype and Ambiguous Leukemias0
Applications of Noninvasive Prenatal Testing for Subchromosomal Copy Number Variations Using Cell-Free DNA0
The Mass Spectrometry Revolution in Clinical Microbiology Part 10
Pan-Cancer Molecular Biomarkers0
Copyright0
Significance of SF3B1 Mutations in Myeloid Neoplasms0
Routine Coagulation0
Novel Clinical and Laboratory Correlations for Antiphospholipid Syndrome0
Forthcoming Issues0
Working with the Electronic Health Record and Laboratory Information System to Maximize Ordering and Reporting of Molecular Microbiology Results0
Artificial Intelligence in the Clinical Laboratory: Current Practice and Emerging Opportunities0
Present and Future Non-Culture-Based Diagnostics: Stewardship Potentials and Considerations0
Copyright0
Severe Acute Respiratory Syndrome Coronavirus 2 Antigens as Targets of Antibody Responses0
Building, Promoting and Maintaining a Culture of Psychological Safety and Resilience in the Laboratory0
Contributors0
Carbapenemase Mechanism Testing to Support Treatment, Infection Control, and Public Health0
Copyright0
Copyright0
Molecular Diagnostic Testing for Hematopoietic Neoplasms0
Molecular Pathology of Mature Lymphoid Malignancies0
Review of SARS-CoV-2 Antigen and Antibody Testing in Diagnosis and Community Surveillance0
A Review of the Flow Cytometric Findings in Classic Hodgkin Lymphoma, Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte-Rich Large B Cell Lymphoma0
Contributors0
Severe Acute Respiratory Syndrome Coronavirus 2 Serology Testing – A Laboratory Primer0
0.06380820274353